The State of the Pharmaceutical Supply Chain Safety and Security
Counterfeit medicines are a $32 billion global business. For the sake of the general public, as well as to alleviate Congress’ concerns, a process needs to be put in place to ensure a safe and secure supply chain for prescription drugs so that counterfeiting is minimized. However, how are drug companies supposed to know and keep track of where their product is at any time? In this article, Andy Macaleer, Director of Pharmaceutical Solutions, outlines the options available to manufacturers to make this process a reality. With the technologies mentioned in this article, companies can facilitate the authentication of serialized drug product by distributors or retailers, which provides manufacturers with real-time visibility to where its product physically resides at that time in the downstream supply chain.
| Published: | 2007 |
| Format: | |
| Length: | 2 pages |
| Type: | White paper |
| Language: | English |
.
SPONSORED REPORTS
